Stage 5 chronic kidney disease

abnormal lung development, abnormal mitotic spindle morphology, abnormal papillary duct morphology, abnormal placenta vasculature, abnormal placental labyrinth vasculature morphology, abnormal primitive node morphology, abnormal stomach position or orientation, atrioventricular septal defect, dilated bile duct, dilated kidney collecting duct, dilated pancreatic duct, dilated proximal convoluted tubule, dilated renal tubules, embryo phenotype, embryonic lethality during organogenesis, complete penetrance, embryonic lethality during organogenesis, incomplete penetrance, homeostasis/metabolism phenotype, increased cholangiocyte apoptosis, increased circulating creatinine level, increased glomerular capsule space, increased kidney apoptosis, increased kidney cell proliferation, increased kidney weight, increased liver weight, kidney medulla cyst, left pulmonary isomerism, lethality throughout fetal growth and development, complete penetrance, no abnormal phenotype detected, perinatal lethality, incomplete penetrance, postnatal lethality, incomplete penetrance, premature death, prenatal lethality, incomplete penetrance, right pulmonary isomerism, right-sided stomach, situs ambiguus, situs inversus